Evidence map›Paper›PMID 42162939›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2026

Phenotypic diversity of frontotemporal lobar degeneration in two novel GRN variants from Colombia.

Juan Pablo Barbosa-Carvajal, Milena García-García, Luisa Fernanda Gómez Navarro, Victoria Zubiri, Nancy Gelvez, Greizy López, Pablo Reyes, Elkin García-Cifuentes, David Aguillón, Juliana Acosta-Uribe and 1 more

Abstract readCase Reports
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Juan Pablo Barbosa-CarvajalGrupo de Neurociencias de Antioquia, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
Milena García-GarcíaHospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia.
Luisa Fernanda Gómez NavarroGrupo de Neurociencias de Antioquia, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
Victoria ZubiriGrupo de Neurociencias de Antioquia, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
Nancy GelvezFacultada de Medicina, Instituto de Genética Humana, Pontifica Universidad Javeriana, Bogotá, Colombia.
Greizy LópezFacultada de Medicina, Instituto de Genética Humana, Pontifica Universidad Javeriana, Bogotá, Colombia.
Pablo ReyesDepartamento de Psiquiatría y Salud Mental, Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá, Colombia.
Elkin García-CifuentesGrupo de Neurociencias de Antioquia, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
David AguillónGrupo de Neurociencias de Antioquia, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
Juliana Acosta-UribeGrupo de Neurociencias de Antioquia, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
Diana Lucía MatallanaPontificia Universidad Javeriana, Bogotá, Colombia.

Funding

US-South American Initiative for Genetic-Neural-Behavioral Interactions in Human Neurodegenerative ResearchR01AG057234 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Claudia Duran-Aniotz, Agustin M. Ibanez · 2019 to 2026
$6.1M
Research Training in Alzheimer's Disease and Brain Health in ColombiaD43TW012455 · FIC · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DIANA MATALLANA, Hernando Santamaria-Garcia · 2024 to 2026
$733k
Alzheimer's Association SG-20-725707FIC NIH HHS D43 TW012455FIC NIH HHS D43TW012455Intramural Research Program of the NIHNIA NIH HHS R01 AG057234Rainwater Charitable foundation-Tau Consortiumthe Bluefield Project to Cure Frontotemporal Dementiathe National Institutes of Health
6 · The paper itself

Abstract

introductionPathogenic progranulin (GRN) variants are among the main genetic causes of frontotemporal lobar degeneration (FTLD). These variants have been predominantly reported in European cohorts, but their characterization in Latin America remains scarce. We describe two Colombian cases with novel GRN variants with amnestic and semantic syndromes leading to an initial diagnosis of Alzheimer's disease (AD).

methodsWe conducted clinical, neuropsychological, neuroimaging, and genetic analysis. Biomarkers were included for one case.

resultsAt 42 years old, Case 1 presented a predominant amnestic profile and carried the GRN c.21G > A (p.Trp7*) variant. Case 2 debuted with a semantic impairment at 62 years old and was a carrier of GRN c.1098T > A (p.Cys366*) variant. Brain imaging revealed asymmetric temporal atrophy, and biomarkers supported diagnosis of FTLD. DISCUSSION: GRN variants can mimic early-onset AD. An integrative approach including serial clinical, genetic, brain imaging, and biomarker analysis are essential for diagnosing Amnestic variants of FTLD in admixed genetic populations.

Indexed as

Frontotemporal Lobar DegenerationIntercellular Signaling Peptides and ProteinsProgranulinsAdultBrainColombiaFemaleGenetic VariationHumansMagnetic Resonance ImagingMaleMiddle AgedNeuropsychological TestsPhenotypeGRN protein, humanIntercellular Signaling Peptides and ProteinsProgranulinsamnestic syndromeearly‐onset dementiafrontotemporal lobar degenerationgenetic variationprogranulin

Identifiers

PMID42162939
PMCPMC13239240

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.